drugset / Trial / NCT01840345

The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain

NCT01840345

Phase 2 Completed 11 enrolled Virginia Commonwealth University
NaSingle-groupOpen-labelTreatment

Summary

This study will test whether treatment with N-acetyl-L-cysteine (NAC) is safe and decreases pain in patients with chronic neuropathic pain. The investigators hypothesize that NAC will be a useful adjunct to opioid treatment in chronic neuropathic pain.

Timeline

Start
2014-01
Primary completion
2017-03-01
Completion
2017-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg

Indications